IGFBP6 and central nervous system cancer: Specifically, Zong Z. and colleagues recently demonstrated that IGFBP-6 is an unfavorable prognostic factor in glioma, affecting tumor malignancy with an expression positively correlated with the immunosuppressive response in glioma patients [75].